Cargando…

Pulmonary Complications in Patients with Liver Cirrhosis

Patients with advanced chronic liver diseases, particularly with decompensated liver cirrhosis, can develop specific pulmonary complications independently of any pre-existing lung disease. Especially when dyspnea occurs in combination with liver cirrhosis, patients should be evaluated for hepato-pul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benz, Fabian, Mohr, Raphael, Tacke, Frank, Roderburg, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534492/ https://www.ncbi.nlm.nih.gov/pubmed/33062591 http://dx.doi.org/10.2478/jtim-2020-0024

Ejemplares similares

The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis
por: Lambrecht, Joeri, et al.
Publicado: (2021)

From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
por: Mohr, Raphael, et al.
Publicado: (2021)

Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art
por: Laschtowitz, Alena, et al.
Publicado: (2023)

Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
por: Benz, Fabian, et al.
Publicado: (2015)

In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?
por: Mohr, Raphael, et al.
Publicado: (2020)

A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments
por: Özdirik, Burcin, et al.
Publicado: (2020)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
por: Eschrich, Johannes, et al.
Publicado: (2023)

In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
por: Lurje, Isabella, et al.
Publicado: (2021)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review
por: Özdirik, Burcin, et al.
Publicado: (2021)

U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
por: Benz, Fabian, et al.
Publicado: (2013)

Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study
por: Özdirik, Burcin, et al.
Publicado: (2020)

Circulating MicroRNAs as Biomarkers for Sepsis
por: Benz, Fabian, et al.
Publicado: (2016)

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
por: Loosen, Sven H, et al.
Publicado: (2021)

Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2016)

The risk of complications of endoscopic procedures in patients with liver cirrhosis
por: Simon, Krzysztof, et al.
Publicado: (2017)

Human albumin in the management of complications of liver cirrhosis
por: Bernardi, Mauro, et al.
Publicado: (2012)

Pulmonary function testing in patients with liver cirrhosis (Review)
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms
por: Kidess, Evelyn, et al.
Publicado: (2023)

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
por: Mohr, Raphael, et al.
Publicado: (2021)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

The role of the innate immune system in the development and treatment of hepatocellular carcinoma
por: Roderburg, Christoph, et al.
Publicado: (2020)

Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis
por: Roderburg, Christoph, et al.
Publicado: (2012)

Persistently elevated osteopontin serum levels predict mortality in critically ill patients
por: Roderburg, Christoph, et al.
Publicado: (2015)

Serum Levels of miR-143 Predict Survival in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

Step by Step: Managing the Complications of Cirrhosis
por: Perez, Irene C, et al.
Publicado: (2021)

Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2016)

IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2018)

The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2021)

Bleeding complications in critically ill patients with liver cirrhosis
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Usefulness of autotaxin for the complications of liver cirrhosis
por: Shao, Xue, et al.
Publicado: (2020)

Hepatosplenic Sarcoidosis Complicated by Liver Cirrhosis
por: Peters, B., et al.
Publicado: (2015)

Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review
por: Xu, Shixue, et al.
Publicado: (2021)

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
Publicado: (2018)

Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions
por: Liu, Yuan-Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d61qkahqnkt797jo9m2211tafm